Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...

Cambridge CleanTech specialist HutanBio has a new CEO as it bids to expand globally. Paul Beastall, who held the role, ...

Scientists first read the human genome, a three-billion-letter biological book, in April 2003. Since then, researchers have steadily advanced the ability to write DNA, moving far beyond single-gene ...

Bacteriophages have been used therapeutically to treat infectious bacterial diseases for over a century. As ...

By joining forces, IDT will pair its nearly 40-year legacy of quality and service, as well as its global presence, with ...

An updated edition of the Nov. 18, 2025, article. Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this ...

The strategy, known as synthetic biology, is gaining momentum globally as a conservation tool and human health solution, ...

Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering ...

Integrated DNA Technologies collaborates with Ansa Biotechnologies to expand capabilities to IDT’s synthetic biology portfolio: Sunnyvale Saturday, January 17, 2026, 14:00 Hrs [ ...

For more than a century, scientists and doctors have explored the use of bacteriophages — viruses that infect and kill bacteria — to treat infections. With a growing number of bacteria becoming ...

Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic ...